Live
Audio Only
In Spain, the Russian embassy said via Twitter that the Spanish investments advisory company IberAtlantic "is in the negotiation process with the Russian Direct Investment Fund (RDIF) and the biopharmaceutical Zendal in search of a Handshake agreement to produce the Sputnik V in the laboratories of this corporation in Galicia."
Spanish biopharmaceutical group Zenda is interested in producing the Russian Sputnik V vaccine, officials reported on Wednesday.
RELATED:
Zenda sent a letter to the Industry Minister Reyes Maroto highlighting its disposition to manufacture the Sputnik V; a spokesperson told Reuters. This, as other officials have refused to confirm or deny the information "until negotiations are concluded," the agency says.
���������� La empresa IberAtlantic se encuentra en un proceso de negociación con el Fondo Ruso de Inversión Directa @rdif_press y la biofarmacéutica #Zendal en busca de un acuerdo �� para producir la #vacunarusa #SputnikV en los laboratorios de esta corporación en Galicia ���� pic.twitter.com/Iacmc5T7B2
— Rusia en España (@EmbajadaRusaES) March 9, 2021
However, the Russian embassy in Spain said via Twitter that the Spanish investments advisory company IberAtlantic "is in the negotiation process with the Russian Direct Investment Fund (RDIF) and the biopharmaceutical Zendal in search of a Handshake agreement to produce the Sputnik V in the laboratories of this corporation in Galicia."
On the other hand, authorities from the RDIF confirmed on Wednesday to CNN that the Sputnik V vaccine's manufacture in Europe could begin in the summer.
#FromTheSouth News Bits | Union for Hope coalition leader and presidential candidate Andres Arauz signed a preliminary agreement with Russia for the supply of Sputnik V, adding to the commitment made by Argentina to provide Ecuador with 4.4 million doses of the Russian vaccine. pic.twitter.com/VDebUny6qy
— teleSUR English (@telesurenglish) February 3, 2021
Newsletter
